COVID Vaccination in Children and Young People

Our expert speakers will present on evidence based research around recommendations for children globally, disease burden from COVID in children, SA analysis around vaccine uptake, clinical trials of COVID in children and adolescents and the proposed rollout in South Australia.

OUR SPEAKERS

Professor Helen Marshall, Senior Medical Practitioner and Director, Vaccinology and Immunology Research Trials Unit, Women's and Children's Hospital / NHMRC Practitioner Fellow and Professor in Vaccinology, Adelaide Medical School, University of Adelaide / Deputy Director and Research Leader, Robinson Research Institute, University of Adelaide

COVID and kids

Professor Helen Marshall MBBS DCH MPH MD is a clinician researcher and NHMRC Practitioner Fellow with specialist training in child health, public health and vaccinology having completed a Bachelor of Medicine and Surgery, Doctorate of Medicine, Master of Public Health and Diploma in Child Health and the Advanced Vaccinology Course at the Pasteur Merieux Institute, France. She holds the position Professor in Vaccinology in the Adelaide Medical School and is the Deputy Director of the Robinson Research Institute at the University of Adelaide, Consultant in Vaccinology, at the Women’s and Children’s Hospital, South Australia. She is an international leader in vaccines and vaccine preventable diseases. She was awarded the NHMRC’s “10 of the Best” research projects nationally and the SA Science Award for Excellence in Research for the Public Good and SA Science Award for Excellence in Research Collaboration. In 2020 she received the Inspiring South Australian Women award, Australia Day Council, South Australia.

Professor Jonathan Craig, Vice President and Executive Dean & Matthew Flinders Distinguished Professor, College of Medicine and Public Health, Flinders University

Clinical trials of COVID in children and adolescents

Professor Jonathan Craig is an internationally recognised clinician and scientist and has made a significant contribution to the clinical research landscape in the prevention, identification, management and treatment of chronic kidney disease, particularly in relation to children and in Indigenous communities. He has led the formation of state, national and international networks to conduct high-quality, relevant trials in children and has been instrumental to the development and implementation of best-practice methods and guidelines relating to chronic kidney disease in Australia and globally. His current advisory roles include member of the National Health and Medical Research Council’s Health Translation Advisory Committee, the Pharmaceutical Benefits Advisory Committee, Medical Services Advisory Committee and Commonwealth Department of Health Life Savings Drug Program. He is a past member of the WHO expert review panel for global strategy and plan of action on public health, innovation and intellectual property, a past chairman of the Steering Group of the Cochrane Collaboration, and a past member of the Expert Advisory Group for the Structural Review of NHMRC’s Grant Program.

Dr Emily Kirkpatrick, Deputy Chief Medical Officer, Deputy Chief Public Health Officer, Department for Health and Wellbeing, SA Health

Paediatric COVID vaccine rollout in South Australia: Ensuring an evidence-based, yet a practical approach to the vaccine rollout in SA

Dr Emily Kirkpatrick BMed MMed MPH DCH GCHPE CHIA MAICD FRACGP is the Deputy Chief Medical Officer and a Deputy Chief Public Health Officer at SA Health, focusing on the COVID-19 response with her focus on quarantine and vaccination. Emily has completed a Master of Public Health and subsequently a Master of Medicine, with her research focusing on cancer screening programs and preventative healthcare. She is fellow of the RACGP and a practising GP. Her public health and population health knowledge have been invaluable in her strategic advice to SA Health & GPs during the COVID-19 pandemic. In particular, she currently is the chief clinical lead of the SA Health quarantine programme and co-chairs the SA Health COVID vaccine clinical advisory group. Emily is passionate about patient-centred care outcomes using data, metrics and patient reported outcome measures to drive decision making.

OUR CHAIR

Professor Claire Roberts (HDA Co-Convenor), NHMRC Leadership Fellow / Professor and Matthew Flinders Fellow / Group Leader, Pregnancy Health and Beyond Laboratory (PHaB Lab), College of Medicine and Public Health, Flinders University.

The speaker session concludes at 7.30pm. We are unable to hold networking/light refreshments following the session due to capacity restrictions.

This event will be held under COVID-SAFE guidelines. Seating will be limited. Please only register if you intend to attend in person. TICKETS REQUIRED ON ENTRY.

The University of Adelaide is following SA Health social distancing and personal hygiene guidelines.

Event Venue & Nearby Stays

The Braggs, G60 Braggs Lecture Theatre, Victoria Drive, Adelaide, Australia